| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| 119.434 sh Altria Group Inc. | 2012-03 | Purchased | 2015-01 | sold in stock market | 6,354 | 3,362 | 0 | 2,992 | ||
| 125 sh Bristol Myers Squibb Co | 2012-03 | Purchased | 2015-12 | sold in stock market | 7,625 | 4,227 | 0 | 3,398 | ||
| 200 sh Nextera Energy Inc | 2013-10 | Purchased | 2015-12 | sold in stock market | 20,039 | 17,536 | 0 | 2,503 | ||
| 45 sh Sempra Energy | 2012-03 | Purchased | 2015-01 | sold in stock market | 5,005 | 2,707 | 0 | 2,298 | ||
| 53.719 sh Johnson & Johnson | 2010-09 | Purchased | 2015-01 | sold in stock market | 5,347 | 3,366 | 0 | 1,981 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| Equities | AT COST | 239,947 | 289,609 |
| Description | Amount |
|---|---|
| 2012 loan receivable payment not recorded | 16,042 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Bank and broker fees | 225 | 0 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Federal tax | 170 | 0 | 0 |